Released May 14, 2014, after the close
10-Q filed May 14, 2014, 44 days after period end · 0001144204-14-030423
Q1 2014 · 10-Q
Revenue—
Net Income-$4.07M-$4.07M N/M vs Q1 2013N/M vs Q4 2013
EPS Diluted-$0.92-$0.92 N/M vs Q1 2013no prior Q4 2013 on file
Operating Income-$4,110,151N/M
Operating Cash Flow-$5,185,061N/M
Free Cash Flowderived-$5,187,650N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | -$4.07M | -$3.72M | -$8.17M | -$2.72M |
| EPS Diluted | -$0.92 | -$0.22 | -$0.66 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR